AI assistant
HARVARD BIOSCIENCE INC — Director's Dealing 2012
Dec 13, 2012
34975_dirs_2012-12-13_21999b56-0b75-47a3-82f8-185f1d780239.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: HARVARD BIOSCIENCE INC (HBIO)
CIK: 0001123494
Period of Report: 2012-12-11
Reporting Person: LUSCINSKI SUSAN M (Chief Operating Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2012-12-11 | Common Stock | M | 100000 | $3.16 | Acquired | 436596 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2012-12-11 | Stock Option (right to buy) | $3.16 | M | 100000 | Disposed | 2013-04-08 | Common Stock, par value $0.01 per share (100000) | Direct |
Footnotes
F1: Includes (a) a deferred stock award of 33,400 restricted stock units which vest in equal installments on Jan 1, 2013 and Jan 1, 2014; (b) a deferred stock award of 14,062 restricted stock units which vest in equal installments on Jan 1, 2013, Jan 1, 2014 and Jan 1, 2015; (c) a deferred stock award of 41,273 restricted stock units which vest in equal installments on Jan 1, 2013, Jan 1, 2014, Jan 1, 2015 and Jan 1, 2016; and (d) 347,861 shares of common stock held by Ms. Luscinski.
F2: Represents exercise of stock options granted pursuant to the Issuer's 2000 Stock Option and Incentive Plan